Delivery Order SPE2DX22D0029-SPE2D825F41CB

The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,068.48 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. No set-aside designation was applied to this award.

As a critical federal medical procurement vendor, AmerisourceBergen supplies pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Medical Supply Chain relies on AmerisourceBergen as a prime vendor to fulfill diverse pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to support global military healthcare programs.